From: ACLY facilitates colon cancer cell metastasis by CTNNB1
Protein name | Â | ACLY | CTNNB1 | ||||
---|---|---|---|---|---|---|---|
Characteristics | All cases | Low | High | P value | Low | High | P value |
Participants | 78 | 32 | 46 | Â | 44 | 34 | Â |
Age (years) | Â | Â | Â | 0.058 | Â | Â | 0.712 |
 <60 | 27 | 15 | 12 |  | 16 | 11 |  |
 ≥60 | 51 | 17 | 34 |  | 28 | 23 |  |
Gender | Â | Â | Â | 0.414 | Â | Â | 0.751 |
 Male | 42 | 19 | 23 |  | 23 | 19 |  |
 Female | 36 | 13 | 23 |  | 21 | 15 |  |
AJCC clinical stage | Â | Â | Â | 0.081 | Â | Â | 0.040 |
 1–2 | 50 | 25 | 25 |  | 33 | 17 |  |
 3–4 | 28 | 7 | 21 |  | 11 | 17 |  |
Tumor size (mm3) | Â | Â | Â | 0.516 | Â | Â | 0.117 |
 <30 | 38 | 17 | 21 |  | 18 | 20 |  |
 ≥30 | 40 | 15 | 25 |  | 26 | 14 |  |
Lymphnode metastasis | Â | Â | Â | 0.049 | Â | Â | 0.042 |
 Negative | 51 | 25 | 26 |  | 33 | 18 |  |
 Positive | 27 | 7 | 20 |  | 11 | 16 |  |